Recombinant FSH versus urinary gonadotrophins or recombinant FSH for ovulation induction in subfertility associated with polycystic ovary syndrome
Editorial Group: Cochrane Menstrual Disorders and Subfertility Group
Published Online: 23 APR 2001
Assessed as up-to-date: 27 FEB 2001
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Bayram N, van Wely M, Van der Veen F. Recombinant FSH versus urinary gonadotrophins or recombinant FSH for ovulation induction in subfertility associated with polycystic ovary syndrome. Cochrane Database of Systematic Reviews 2001, Issue 2. Art. No.: CD002121. DOI: 10.1002/14651858.CD002121.
- Publication Status: Edited (no change to conclusions)
- Published Online: 23 APR 2001
This article has been cited by:
- 1Induction of ovulation, Obstetrics, Gynaecology & Reproductive Medicine, 2011, 21, 2, 47, ,
- 2Depressive Symptoms Related to Infertility and Infertility Treatments, Psychiatric Clinics of North America, 2010, 33, 2, 309, , ,
- 3Clinical efficacy of highly purified urinary FSH versus recombinant FSH in volunteers undergoing controlled ovarian stimulation for in vitro fertilization: a randomized, multicenter, investigator-blind trial, Fertility and Sterility, 2009, 91, 4, 1005, , , , , , ,
- 4Use of exogenous gonadotropins in anovulatory women: a technical bulletin, Fertility and Sterility, 2008, 90, 5, S7
- 5Le coasting et les protocoles de stimulation chez les hyperrépondeuses en AMP, Gynécologie Obstétrique & Fertilité, 2005, 33, 9, 703, , , , , , ,
- 6Assessment and management of anovulatory infertility in polycystic ovary syndrome, Endocrinology and Metabolism Clinics of North America, 2003, 32, 3, 639,